ENDRA Life Sciences 8-K Filing
ENDRA Life Sciences files 8-K with material definitive agreement and unregistered equity sales. Filing includes financial statements and exhibits.
Filed: 2026-05-28 AccNo: 0001213900-26-061701 Size: 742 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits